Monitor Aurora shareholder tender response and any competing bids or regulatory hurdles. The December 1 deadline is a key catalyst. Watch for Aurora board's next defensive move or any shareholder litigation.
Price Chart
Executive Summary
Curaleaf published a brochure directly appealing to Aurora shareholders to tender their shares to its hostile takeover bid, reiterating a 45% premium and criticizing Aurora's management. The filing is a continuation of Curaleaf's campaign to bypass Aurora's board and take the offer directly to shareholders, with a tender deadline of December 1, 2026.
Key Financial Metrics
Key Facts
- Curaleaf is offering 0.3463 Curaleaf shares and US$0.75 cash per Aurora share, implying an offer price of US$4.00 per Aurora share.
- The offer represents a 45% premium to Aurora's 30-day VWAP as of August 10, 2026.
- Combined entity would have more than US$1.5 billion in LTM revenue and nearly US$350 million in LTM adjusted EBITDA.
- Curaleaf expects at least US$40 million in annual cost synergies from the combination.
- Aurora shareholders must tender their shares before December 1, 2026.
- Curaleaf claims Aurora's net revenue declined 14% and adjusted EBITDA declined 78% over the last four quarters.
- Curaleaf states its own share price increased approximately 50% in the first six months of 2026, while Aurora's declined approximately 34%.
Financial Impact
Offer values Aurora at US$4.00/share, a 45% premium to the unaffected price. Combined entity would have >US$1.5B LTM revenue and ~US$350M LTM adjusted EBITDA, with at least US$40M in expected annual cost synergies.
Risk Factors
- Aurora board continues to reject the offer, potentially seeking a white knight or poison pill.
- Regulatory approvals in multiple jurisdictions (17 countries) could delay or block the deal.
- Shareholder apathy or insufficient tender could cause the bid to fail.
- Integration risks and synergy realization may fall short of projections.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001756770-26-000110 |
| Document: curaleafbrochure_final.htm | 0001756770-26-000110 |
| Document: 0001756770-26-000110-index-headers.html | 0001756770-26-000110 |
| Document: 0001756770-26-000110-index.html | 0001756770-26-000110 |
| Document: 0001756770-26-000110.txt | 0001756770-26-000110 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 425 / 8-K | $7.86 $8.12 | ▲ +3.30% | ▲ +2.77% | $8.00 (+1.78%) |
Oct 6, 2026 20d ago | 425 | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.00 (−19.92%) |
Oct 6, 2026 20d ago | 8-K | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.00 (−19.92%) |
Oct 6, 2026 20d ago | 425 | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.00 (−19.92%) |
Oct 6, 2026 20d ago | 8-K | $9.99 $9.85 | ▼ −1.40% | ▼ −1.16% | $8.00 (−19.92%) |
Oct 1, 2026 25d ago | 8-K | $9.95 $9.76 | ▼ −1.91% | ▼ −2.58% | $8.00 (−19.60%) |
Oct 1, 2026 25d ago | 8-K | $9.95 $9.76 | ▼ −1.91% | ▼ −2.58% | $8.00 (−19.60%) |
Sep 16, 2026 5w ago | 8-K | $9.98 $10.26 | ▲ +2.81% | ▲ +1.67% | $8.00 (−19.84%) |
Sep 16, 2026 5w ago | 425 | $9.98 $10.26 | ▲ +2.81% | ▲ +1.67% | $8.00 (−19.84%) |
Sep 15, 2026 5w ago | 425 / 8-K | $10.12 $10.13 | ▲ +0.10% | ▼ −0.23% | $8.00 (−20.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers